Mitral Valve Prolapse: Definition, Uses, and Clinical Overview

Posted on February 27, 2026 | by drcardiac

Mitral Valve Prolapse Introduction (What it is)

Mitral Valve Prolapse is a condition in which the mitral valve leaflets bow backward into the left atrium during heart contraction.
It is most often discussed in relation to mitral regurgitation, a “leak” of blood backward through the valve.
It is commonly identified on echocardiography (cardiac ultrasound) and described in cardiology reports.
It can be found incidentally or during evaluation of symptoms such as palpitations or shortness of breath.

Why Mitral Valve Prolapse used (Purpose / benefits)

Mitral Valve Prolapse is a diagnostic term that helps clinicians describe a specific valve motion and structure. Its main “purpose” is not therapeutic (it is not a treatment), but clinical: it provides a framework for evaluating symptoms, estimating risk, and planning follow-up.

In practice, identifying Mitral Valve Prolapse can help with:

Explaining physical exam findings. A midsystolic click and/or murmur may be related to valve leaflet motion and associated regurgitation.
Clarifying the cause of mitral regurgitation. Mitral regurgitation can be caused by several mechanisms; Mitral Valve Prolapse is one of the common degenerative (structural) causes.
Risk stratification. The presence and severity of mitral regurgitation, leaflet features, and heart chamber size/function can influence how clinicians interpret future risk and monitoring needs.
Symptom evaluation. Symptoms such as palpitations, atypical chest discomfort, exercise intolerance, or breathlessness may prompt assessment of the mitral valve and heart rhythm.
Guiding timing of further testing. The diagnosis often triggers consideration of follow-up imaging and, in selected scenarios, additional rhythm monitoring or more detailed valve imaging.
Supporting communication across teams. The term is used by cardiologists, primary care clinicians, imaging specialists, and cardiothoracic teams to describe anatomy consistently.

Clinical context (When cardiologists or cardiovascular clinicians use it)

Mitral Valve Prolapse is typically referenced or assessed in these settings:

A heart murmur is detected on routine exam and an echocardiogram is ordered.
A patient reports palpitations, and clinicians evaluate for rhythm issues and potential valve disease.
Shortness of breath, reduced exercise tolerance, or fatigue prompts evaluation for mitral regurgitation and its hemodynamic impact.
Incidental finding on an echocardiogram performed for another reason (for example, hypertension workup or preoperative assessment).
Follow-up of known mitral regurgitation, especially when the mechanism is suspected to be degenerative leaflet prolapse.
Assessment after infective endocarditis or other conditions that can affect valve structure, to distinguish prolapse from other leaflet abnormalities.
Pre-procedural planning when mitral valve repair is being considered, where mechanism (which leaflet segments are involved) matters.
Evaluation of specific phenotypes, such as bileaflet prolapse or features associated with arrhythmias, when clinically suspected.

Contraindications / when it’s NOT ideal

Because Mitral Valve Prolapse is a diagnosis and descriptive finding (not a device or medication), “contraindications” are best understood as situations where the label is not appropriate, where it may be over-applied, or where another explanation better fits the findings.

Situations where calling something Mitral Valve Prolapse may not be ideal include:

Echocardiographic criteria are not met. Mild leaflet motion can be misclassified, especially if imaging planes are suboptimal or the annular shape is not fully appreciated.
Mitral regurgitation is present but due to another mechanism. Examples include functional/secondary mitral regurgitation from left ventricular dilation, ischemic tethering after myocardial infarction, or rheumatic valve disease—conditions where leaflet “prolapse” is not the primary problem.
Apparent prolapse caused by imaging artifact. Off-axis views, poor acoustic windows, and certain loading conditions can mimic leaflet displacement.
Symptoms are attributed to prolapse without supportive evidence. Palpitations or chest discomfort can have many causes; clinicians generally aim to avoid anchoring on Mitral Valve Prolapse unless the overall picture fits.
A more urgent structural abnormality is present. A flail leaflet from chordal rupture, acute severe mitral regurgitation, or endocarditis-related perforation may require different terminology and a different clinical pathway.
When a more specific diagnosis is needed. For procedural planning, teams may move beyond “Mitral Valve Prolapse” to detailed segmental anatomy (e.g., specific scallops) and mechanism-based classification.

How it works (Mechanism / physiology)

Mitral Valve Prolapse reflects a mechanical behavior of the mitral valve during the cardiac cycle.

Mechanism and physiologic principle

The mitral valve sits between the left atrium (receiving oxygenated blood from the lungs) and the left ventricle (pumping blood to the body).
During ventricular contraction (systole), the mitral valve should close so blood flows forward through the aortic valve.
In Mitral Valve Prolapse, one or both mitral leaflets billow upward into the left atrium during systole.
Prolapse may occur with or without significant leakage. When the valve does not seal effectively, mitral regurgitation occurs, meaning some blood flows backward into the left atrium.

Relevant anatomy and supporting structures

Mitral valve function depends on a coordinated set of structures:

Leaflets (anterior and posterior): the “doors” that open and close.
Mitral annulus: the fibrous ring anchoring the leaflets; its shape changes during the heartbeat.
Chordae tendineae: fibrous cords that tether leaflets.
Papillary muscles: muscles in the left ventricle that hold chordae and stabilize leaflet closure.
Left atrium and left ventricle: chamber sizes and pressures influence how the valve behaves.

Degenerative changes (often described as myxomatous changes) can make leaflets thicker and more redundant, and chordae may stretch. In some cases, chordae can rupture, creating a flail leaflet with more dramatic regurgitation.

Time course and clinical interpretation

Mitral Valve Prolapse is often a chronic finding and may remain stable for long periods.
The clinical significance is frequently driven by the degree of mitral regurgitation, the response of the left atrium and ventricle (dilation, function), and symptom burden.
The finding itself can be dynamic, meaning the degree of prolapse/regurgitation can vary with blood pressure, volume status, and heart rate.

Mitral Valve Prolapse Procedure overview (How it’s applied)

Mitral Valve Prolapse is not a procedure. It is most often assessed and characterized through clinical evaluation and cardiac imaging, then followed over time if relevant.

A typical high-level workflow looks like this:

Evaluation / exam – Review symptoms (if any), personal and family history, and cardiovascular risk factors. – Cardiac exam for clicks and murmurs and assessment for signs of heart failure (when present).
Preparation – Many assessments require minimal preparation (for example, a standard transthoracic echocardiogram). – If more detailed imaging is needed, clinicians may consider additional modalities; preparation varies by test and facility.
Testing / imaging – Transthoracic echocardiography (TTE) is commonly used to confirm Mitral Valve Prolapse and assess mitral regurgitation severity and chamber size/function. – When needed, transesophageal echocardiography (TEE) can provide higher-resolution views of leaflet segments and mechanism. – In selected situations, stress echocardiography, cardiac MRI, or CT may be used to refine severity assessment or anatomy.
Immediate checks and interpretation – Clinicians interpret whether prolapse is present, whether regurgitation exists, and whether there are associated findings (e.g., left atrial enlargement, left ventricular size/function changes, pulmonary pressures). – If palpitations or syncope is reported, rhythm assessment (ECG and sometimes ambulatory monitoring) may be included; the approach varies by clinician and case.
Follow-up – Follow-up plans are individualized and commonly depend on regurgitation severity, symptoms, and changes in heart size/function over time. – If severe regurgitation or complications are suspected, referral to a valve-focused team may be considered.

Types / variations

Mitral Valve Prolapse is not a single uniform entity. Clinicians often describe it using variations that reflect anatomy, severity, and mechanism.

Common ways it is categorized include:

By leaflet involvement
Posterior leaflet prolapse
Anterior leaflet prolapse
Bileaflet prolapse (both leaflets)
By associated mitral regurgitation
Prolapse without significant regurgitation
Prolapse with mild, moderate, or severe regurgitation (grading methods vary by lab and measurement set)
By tissue characteristics / degenerative pattern
Myxomatous (Barlow-type) degeneration: often thicker, more redundant leaflets and annular changes
Fibroelastic deficiency: often thinner leaflets with more focal chordal issues (terminology and classification can vary)
By chordal status
Prolapse with elongated chordae
Prolapse with ruptured chordae leading to flail leaflet
By clinical phenotype
Asymptomatic incidental Mitral Valve Prolapse
Prolapse associated with arrhythmias/palpitations (sometimes referred to in discussions as an “arrhythmic” phenotype; definitions vary by clinician and case)
Prolapse associated with connective tissue disorders (e.g., Marfan syndrome or Ehlers-Danlos syndrome), where valve features may coexist with broader cardiovascular findings

Pros and cons

Pros:

Helps identify a structural mechanism behind a murmur or mitral regurgitation.
Supports standardized communication among clinicians and imaging teams.
Allows tracking over time, especially when regurgitation is present.
Can inform risk-aware follow-up based on valve function and heart chamber response.
Encourages a mechanism-based approach to mitral regurgitation (important when interventions are considered).
Often provides reassurance when regurgitation is minimal and heart structure/function are normal (interpretation varies by clinician and case).

Cons:

The term can cause unnecessary anxiety when prolapse is mild and clinically insignificant.
Diagnostic thresholds and imaging interpretation can vary across labs and operators.
Prolapse severity and regurgitation can be dynamic, making single-time assessments imperfect.
Symptoms like palpitations or chest discomfort are not specific to prolapse and may be incorrectly attributed to it.
The label may oversimplify complex valve mechanisms that require more detailed segmental description.
Management decisions are usually driven by regurgitation severity and cardiac effects, not the presence of prolapse alone, which can be confusing for patients.

Aftercare & longevity

There is no universal “aftercare” for Mitral Valve Prolapse as a diagnosis, but there is often a long-term plan for monitoring and cardiovascular health maintenance that reflects the severity of associated valve dysfunction.

Factors that commonly influence long-term course and “longevity” of valve function include:

Severity of mitral regurgitation, if present, and whether it changes over time.
Left atrial and left ventricular size and function, which reflect how the heart is adapting to valve leakage.
Blood pressure and overall cardiovascular risk profile, which can influence cardiac workload.
Heart rhythm issues, such as atrial fibrillation or frequent premature beats, when they occur.
Coexisting conditions (e.g., connective tissue disorders, coronary disease) that may affect overall cardiovascular status.
Consistency of follow-up, including periodic imaging when clinicians consider it appropriate; intervals vary by clinician and case.
If an intervention is performed for mitral regurgitation (such as repair), longer-term results can depend on valve anatomy, technique, and patient factors; outcomes vary by clinician and case.

In general educational terms, discussions after diagnosis often include what symptoms to report, how follow-up imaging might be used, and how clinicians watch for changes in valve leakage or heart chamber size.

Alternatives / comparisons

Mitral Valve Prolapse is best understood in contrast to other explanations for mitral regurgitation or for symptoms that prompt cardiac evaluation.

Mitral Valve Prolapse vs observation/monitoring

Observation/monitoring is not an alternative diagnosis; it is a common management pathway when prolapse is present but regurgitation is mild and heart structure/function are reassuring.
Monitoring typically focuses on symptoms, physical exam findings, and periodic imaging when indicated; the approach varies by clinician and case.

Mitral Valve Prolapse vs other causes of mitral regurgitation

Primary (degenerative) MR due to prolapse: leaflet/chordal structural problem is central.
Secondary (functional) MR: the valve may be structurally normal, but the ventricle is dilated or distorted (for example, cardiomyopathy or ischemic remodeling), preventing adequate leaflet closure.
Rheumatic disease, endocarditis, or congenital abnormalities: may cause restricted leaflet motion, perforation, scarring, or other mechanisms distinct from prolapse.

Comparisons among imaging modalities

TTE (standard echo): first-line, noninvasive, widely available.
TEE: more invasive (probe in the esophagus) but can better define leaflet anatomy and mechanism in many patients.
Cardiac MRI: can quantify ventricular volumes and regurgitant volume/fraction in many cases; availability and protocols vary.
CT: may be used for anatomic assessment or procedural planning in selected settings; it is not the primary test for diagnosing prolapse.

When procedures enter the conversation

If mitral regurgitation becomes severe or causes meaningful cardiac changes, clinicians may compare medical management and monitoring with interventional options (surgical repair/replacement or transcatheter approaches in selected patients). These comparisons depend heavily on anatomy, symptoms, imaging results, surgical risk, and local expertise—so recommendations vary by clinician and case.

Mitral Valve Prolapse Common questions (FAQ)

Q: Is Mitral Valve Prolapse dangerous?
Mitral Valve Prolapse spans a wide spectrum. Many people have minimal or no mitral regurgitation and remain stable for long periods. When regurgitation is moderate to severe, clinicians pay closer attention to symptoms and heart chamber changes, because those features influence clinical significance.

Q: Can Mitral Valve Prolapse cause chest pain?
Some people with Mitral Valve Prolapse report chest discomfort, but chest pain has many possible causes, including non-cardiac causes. Clinicians typically evaluate chest pain based on the overall risk profile and associated symptoms rather than assuming prolapse is the cause.

Q: Why do palpitations happen with Mitral Valve Prolapse?
Palpitations can occur for many reasons, including benign extra beats or more sustained arrhythmias. In some individuals, Mitral Valve Prolapse is discussed alongside rhythm symptoms, and clinicians may use ECG testing or ambulatory monitoring to clarify what rhythm is present. The relationship varies by clinician and case.

Q: Does Mitral Valve Prolapse always lead to mitral regurgitation?
No. Prolapse can exist with little to no regurgitation. When regurgitation occurs, its severity depends on how well the leaflets coapt (seal), chordal integrity, annular motion, and loading conditions.

Q: How is Mitral Valve Prolapse diagnosed?
It is most commonly diagnosed with echocardiography, which can visualize leaflet motion during systole and assess regurgitation and heart chamber size/function. The exam may be prompted by a murmur, symptoms, or an incidental finding.

Q: Will I need surgery if I have Mitral Valve Prolapse?
Many people do not require any procedure. Interventions are generally discussed when mitral regurgitation is severe, symptoms are significant, or imaging shows meaningful effects on heart structure/function; specifics vary by clinician and case.

Q: How long do the results “last” if mitral regurgitation is treated?
If a procedure is performed (most commonly valve repair when feasible), durability depends on valve anatomy, technique, and patient factors. Long-term performance varies by clinician and case, and follow-up imaging is commonly used to track valve function over time.

Q: Is it safe to exercise with Mitral Valve Prolapse?
Many individuals remain active without limitation, especially when regurgitation is mild and there are no concerning symptoms. Exercise guidance is typically individualized based on regurgitation severity, rhythm findings, symptoms, and overall cardiovascular status.

Q: Will I need to stay in the hospital?
Diagnosis by outpatient echocardiography usually does not require hospitalization. Hospital stays are more relevant if complications occur (such as acute severe regurgitation or significant arrhythmias) or if an intervention is performed; the setting depends on the situation.

Q: What does Mitral Valve Prolapse cost to evaluate?
Costs vary widely based on location, insurance coverage, and which tests are used (for example, TTE versus TEE or MRI). Clinicians and facilities often frame evaluation in stepwise fashion, starting with less invasive testing and escalating when needed.